Biotech, cancer, Allergies
Supersized Ambitions: VentiRx Aims to be Extra-Large Player in Cancer, Allergy Medicines
Luke Timmerman 1/7/09
They love their coffee at VentiRx. They love it so much that they named their San Diego- and Seattle-based biotech company after the extra-large size of beverage containers that Starbucks shrewdly branded for its menu. The name also happens to symbolize VentiRx’s supersize ambitions for creating new drugs against cancer and inflammatory diseases.
Naturally, I had to catch up with the company’s scientific co-founder, Rob Hershberg, at a Starbucks in downtown Seattle and order a venti coffee myself. (I think he... Read more »





